Alkem Laboratories launches Cetuxa. World’s first biosimilar of Cetuximab for Head and Neck Cancer.
May 29, 2023
Source link
Q3FY23 Results, Press Release and Investor Presentation February 10, 2023
Q3FY23 Results, Press Release and Investor Presentation February 10, 2023 Source link